Member Info for TorquayFan

Chester. C7 last seen on ADVFN. Mooted - 'away for a couple of days' or something like that. Impliedly in treatment ? Hope he's OK.
By my reckoning you have 90 mins to get to Oxford ! ATB

Botski - my Dad was in Foggia with a squadron of 'Liberators' at the end of WW2 - disappointed to have left Biggin Hill's Spitfires. Puglia is a beautiful area I believe. I'm guessing BoD caught you out with the 'early' AGM ?

So it's full steam ahead for the AGM - look forward to all comments from Attendees. GLA

''Hong Kong strife holds up almost $100M of BioNTech's Series B haul . . .''

''The trade tension between China and the United States has reverberated in the biopharma industry. Last year the Committee on Foreign Investment in the United States (CFIUS) — a federal interagency committee chaired by the US Treasury Department — expanded its review of foreign investment in the biotechnology sector, citing national security reasons, triggering concern that US biotechs may have trouble accessing Chinese money. And in recent months, MD Anderson Cancer Center sanctioned five of its own researchers — three of whom were ethnically Chinese — for purportedly violating conflict of interest policies, alleging ‘foreign influence’, after the NIH requested the institution investigate their conduct . . . . .''

''Most of BioNTech’s clinical assets are messenger RNA therapies (mRNA), a family of treatments in which a natural system is harnessed to send the body a signal to produce its own drug — in this case, to fight cancer. The company also has cell therapies and antibodies in its arsenal. Altogether, the company has 20 product candidates, of which eight have entered into nine ongoing clinical trials.''

I wonder if RG's efforts in China are/will be affected by these 'trade tensions' ?

https://endpts.com/honk-kong-strife-holds-up-almost-100m-of-biontechs-series-b-haul-filing/

Margaret A - Is this in the lull after, before, or going down in, the storm ?
Who wouldn't be a Prof. Lindy supporter or a Scancell supporter or disappointed sometimes.

Thanks Inan. And all the posts today. Happy AGM to all !

Earlier re. BioNTech - ''CEO Ugur Sahin has a 18.80% stake''. No wonder the CEO is smiling !

And lots more to smile about in BioNTech's 'Development' program, including Scancell.

Wish I hadn't mentioned it now ! The point being Crumbs, that a 'casual Observer' might be surprised that Scancell has a P/T CSO even though such an arrangement is NOT unique and actually, it's a format which can work extremely well - (as it has for Scancell - we all agree).

I agree it's not likely to be relevant to the SP / 7 pence issue but I think that might have been the suggestion. That's all. Another coffee.

I wonder if we'll have news today ? And some more blue - 'every little helps'.

''Sahin is still uni connected and not full-time BioNtech either....''

That's very interesting. I guess with Researchers, not being wholly in the commercial tunnel might keep the vision wider, if you see what I mean. But Sahin is CEO.

Come on BioNTech, Scancell and GLA

That's the way it is and that's 100% OK for me, if it is for the Prof !

Fact is that we get a massive amount from contacts and interaction with Nottingham University and I'll bet not many in the World has achieved more research progress in Oncology than Prof. Lindy, P/T or not !

Chester - Crumbs posted 'highly insulting BS' to Moljen - unfair in the context and rather more than abrasive.

It's been a great day on LSE today - thanks all.

Nice snippet Crumbs . . . .

Another look from 'Endpoints' :-

''Helmut Jeggle, who is responsible for the life science initiatives of the Strüngmann brothers, holds about 50.35% of BioNTech’s shares, while the company’s CEO Ugur Sahin has a 18.80% stake.'' No wonder the CEO is smiling !

https://endpts.com/fresh-off-the-heels-of-mega-financing-round-germanys-biontech-makes-100m-us-ipo-play/

Ray does finish his post 'LOL' Ruck. But if collaborations with Scancell do progress to monetization, then IMO the deeper BioNTech's pockets - the better ! We'll see . . .

Has anyone else received this from CRUK ? Jolly nice of them to think of me but I'm not sure I'm very well qualified to help . . . .

''Dear (Torquay Fan), This summer we’ve been asking for your ideas to help shape the next round of Grand Challenge. Our second challenge-setting workshop gets under way in Milan today with our partners Fondazione AIRC per la Ricerca sul Cancro. We will explore themes including prevention, tumour and host biology and therapeutic approaches. In July, our workshop in Madrid with Fundación Científica de la Asociación Española Contra el Cáncer unearthed some exciting potential challenges, including:

Explain how the cancer connectome defines resistance to treatment
Understand how to prevent metastatic colonisation of tumour cells to combat cancer spread
Map the role of common cancer drivers in normal biology to uncover how to target them in the disease setting

We were also pleased to be joined by Queen Letizia of Spain, FC AECC’s Honorary President.

Our Grand Challenge Advisory Panel, chaired by Sir Paul Nurse, will consider the outputs from these workshops, along with challenge ideas submitted online from our wider community.

We’ll reveal the final Grand Challenges in February 2020 – get ready to apply.''

Moving on, I wonder if discussions continue with other Members of last year's entry ?

GLA

Ray - I know you're joking there but I didn't really think last year's AGM was too confrontational ? I remember some straight questions (in a shortish Q and A) but that's all. This year I think it important for CH to explain/apologise for the FDA/IND matter but otherwise - not too much to bat(tle) about except 7p and monetization. ATB

Inan - "why is scancell at 7p" Indeed.
The science will see us through !

Thanks Bermuda - and there lies a tale . . .

It wasn't actually good news that we lost the USA arm of the SCIB1 Combo - roll on the day the FDA roll over and give the go-ahead at last? If wanted by then.

All this $ around and our Man moves to the UK apparently ?

That's sweet - "indeed what post of ""yours"" fits into that category of actually being able to question my understanding ???" Science 100% yes. The rest is up for grabs.

Repeated unabashed - "You, me and K all have the right to post our views equally do we not ?"

GF - yes it seems we're ALL on a 'yellow card' and there may have been reds ?

Inan - good list thanks. But re. K come to that - 'who is Inan' ?

You, me and K all have the right to post our views equally do we not ?

Elsewhere in reply to some strong talk, I posted, " . . I don't agree that SA is on any particular hook but CH definitely is - the late disclosure of the FDA/IND path to SCIB1 Combo UK arm. Unless there is a mitigating factor (of which we don't know), CH should apologise.''

Maybe that would be better before the tough talk from the floor begins . . .
Could there have been a good reason ? Can't see it . . .

Some bacon would be fine !

Thanks for that Crumbs - what a brilliant address by Prof. Lindy.

She's my 'Woman of the Year' every year ! Clever stuff and I wonder how many of the Attendees really understood it ? A lot of progress since then . . . GLA